BiotechTube
Home/Jasper Therapeutics/Heather Behanna, Ph.D.
HB

Heather Behanna, Ph.D.

SVP, Investor Relations & Corporate Communications

Jasper Therapeutics

Therapeutic Areas

HematologyImmunologyGenetic DisordersOncology

Jasper Therapeutics Pipeline

DrugIndicationPhase
Briquilimab (JSP191)Conditioning for HSCT in Severe Combined Immunodeficiency (SCID)Phase 1/2 / Pivotal Path

Leadership Team at Jasper Therapeutics

RM
Ronald Martell
President and Chief Executive Officer
WW
Wen-Kai Weng, M.D., Ph.D.
Chief Medical Officer
AF
Anna French, Ph.D.
Chief Operating Officer
SH
Scott Harris
General Counsel
ET
Edwin Tucker, M.D.
Chief Financial Officer
View full Jasper Therapeutics profile